Opzelura (Rutinib) Cream 1.5%

How Opzelura Works

Opzelura targets specific immune pathways (JAK-STAT signaling) involved in inflammatory skin conditions. By calming overactive immune responses in the skin, it helps reduce inflammation and associated symptoms without the use of topical steroids.

Key Benefits

• FDA-approved for non-segmental vitiligo and atopic dermatitis

• Helps reduce itching, redness, and inflammation

• Non-steroidal formulation

• Suitable for use on sensitive areas such as the face

• Lightweight, fast-absorbing cream

• Designed for long-term management under medical supervision

Directions for Use

• Apply a thin layer to affected areas twice daily or as prescribed

• Rub in gently until fully absorbed

• Wash hands after application unless treating hands

• Do not apply to more than 10% of body surface area

• Use consistently for best results

Important Safety Information & Precautions

• For external use only

• Avoid contact with eyes, mouth, and mucous membranes

• Do not apply to broken, infected, or irritated skin

• Not approved for children under 12 years

• Tell your healthcare provider if you have a history of:

  • Serious infections

  • Immune system conditions

  • Blood disorders or cancer

• Avoid excessive sun exposure; use sunscreen as recommended

• Discontinue use and seek medical advice if severe irritation or infection occurs

Pregnant or breastfeeding individuals should consult their healthcare provider before use.

Why Choose Opzelura®?

Opzelura represents a new class of targeted dermatology treatments that provide an alternative to topical steroids. It is widely prescribed by dermatologists in the U.S. for patients seeking a modern, science-based approach to managing chronic inflammatory skin conditions.